The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 04, 2023

Filed:

Apr. 12, 2019
Applicant:

National University of Ireland, Galway, Galway, IE;

Inventors:

David Townley, County Clare, IE;

Brian Shields, County Galway, IE;

Ivan Keogh, Galway, IE;

Michele Qi Zhan, Antioch, CA (US);

Conor Farrell, County Mayo, IE;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61N 1/05 (2006.01); A61N 1/40 (2006.01); A61F 7/12 (2006.01); A61B 18/24 (2006.01); A61N 1/18 (2006.01); A61N 1/32 (2006.01); A61N 1/36 (2006.01); A61B 18/14 (2006.01); A61N 1/375 (2006.01); A61B 17/00 (2006.01); A61N 5/02 (2006.01); A61N 7/00 (2006.01); A61B 18/02 (2006.01); A61B 18/18 (2006.01); A61B 18/00 (2006.01); A61F 7/00 (2006.01); A61N 1/06 (2006.01);
U.S. Cl.
CPC ...
A61B 18/24 (2013.01); A61B 17/00234 (2013.01); A61B 18/1492 (2013.01); A61F 7/123 (2013.01); A61N 1/0546 (2013.01); A61N 1/18 (2013.01); A61N 1/32 (2013.01); A61N 1/36017 (2013.01); A61N 1/36082 (2013.01); A61N 1/37518 (2017.08); A61N 1/40 (2013.01); A61N 1/403 (2013.01); A61N 5/022 (2013.01); A61N 7/00 (2013.01); A61B 18/02 (2013.01); A61B 18/0218 (2013.01); A61B 18/1815 (2013.01); A61B 2017/003 (2013.01); A61B 2018/00005 (2013.01); A61B 2018/00011 (2013.01); A61B 2018/0016 (2013.01); A61B 2018/00017 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00023 (2013.01); A61B 2018/0025 (2013.01); A61B 2018/00029 (2013.01); A61B 2018/00035 (2013.01); A61B 2018/00214 (2013.01); A61B 2018/00226 (2013.01); A61B 2018/00232 (2013.01); A61B 2018/00238 (2013.01); A61B 2018/00244 (2013.01); A61B 2018/00255 (2013.01); A61B 2018/00261 (2013.01); A61B 2018/00267 (2013.01); A61B 2018/00327 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00702 (2013.01); A61B 2018/00797 (2013.01); A61B 2018/025 (2013.01); A61B 2018/0212 (2013.01); A61B 2018/0225 (2013.01); A61B 2018/0231 (2013.01); A61B 2018/0237 (2013.01); A61B 2018/0243 (2013.01); A61B 2018/0256 (2013.01); A61B 2018/0262 (2013.01); A61B 2018/0268 (2013.01); A61B 2018/0275 (2013.01); A61B 2018/0281 (2013.01); A61B 2018/0287 (2013.01); A61B 2018/0293 (2013.01); A61B 2018/1467 (2013.01); A61B 2218/002 (2013.01); A61F 7/00 (2013.01); A61F 2007/0006 (2013.01); A61F 2007/0054 (2013.01); A61N 1/06 (2013.01); A61N 1/36025 (2013.01);
Abstract

A device for therapeutic neuromodulation in a nasal region can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.


Find Patent Forward Citations

Loading…